The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial-Reference-Cited by-同舟云学术

The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial

Published:2011-04 Issue:4 Volume:161 Page:755-763
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Beohar Nirat,Davidson Charles J.,Massaro Elaine M.,Srinivas V.S.,Sansing Veronica V.,Zonszein Joel,Davis Andrew M.,Helmy Tarek,Lopes Neuza H.,Thomas Stephen B.,Brooks Maria M.

Funder

National Heart, Lung and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Management of coronary artery disease: therapeutic options in patients with diabetes;Hammoud;J Am Coll Cardiol,2000

2. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N Engl J Med,1998

3. NIDDM and its metabolic control predict coronary heart disease in elderly subjects;Kuusisto;Diabetes,1994

4. Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Rosamond;Circulation,2007

5. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA);Bild;Circulation,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pretransplant Diabetes on Outcomes After Liver Transplantation: An Updated Meta-analysis With Systematic Review;Transplantation;2023-10-30

2. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2022-01-18

3. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization;Journal of the American College of Cardiology;2022-01

4. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24

5. An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes);Journal of the American Heart Association;2017-07